IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress [Yahoo! Finance]
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.50. They now have a "buy" rating on the stock.
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 [Yahoo! Finance]
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024